(Q45788066)

16 December 2017

title

Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment (English)

1 reference

16 December 2017

0 references

1 reference

J. Kruining

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7608475

14 June 2024

R. A. Heijtink

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7608475

14 June 2024

S. W. Schalm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7608475

14 June 2024

language of work or name

1 reference

1 March 1995

1 reference

16 December 2017

full work available at URL

https://repub.eur.nl/pub/73150/REPUB_73150_OA.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7608475

https://api.elsevier.com/content/article/PII:0168827895802770?httpAccept=text/xml

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

https://api.elsevier.com/content/article/PII:0168827895802770?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

14 June 2024

published in

Journal of Hepatology

1 reference

16 December 2017

volume

22

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

page(s)

263-267

1 reference

16 December 2017

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.84.4.1005

Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide

1

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Molecular targets for AIDS therapy

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA.

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

A cell culture assay for compounds which inhibit hepatitis B virus replication

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Multiple sequential periods of DNA synthesis and quiescence in primary hepatocyte cultures maintained on the DMSO-EGF on/off protocol

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

An in vitro system for screening anti-hepatitis B virus drugs

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Future prospects in antiviral therapy

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0168-8278(95)80277-0

14 June 2024

Identifiers

1 reference

16 December 2017

1 reference

16 December 2017